Filing
Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$50,000.00
What the client paid this registrant for the period.
Client based in
California
Lobbyists on this filing
7
-
ROBERT WOODPreviously held: Chief of Staff to HHS Secretary; Intern to Rep. Scott Klug
-
BRENT ALAN DEL MONTEPreviously held: Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee
-
ROBB WALTONPreviously held: Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes
-
JOHN STONEPreviously held: Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C
-
REMY LEIGH BRIM MASONPreviously held: Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz
-
JOEL D. BAILEYPreviously held: COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall
-
RAGHAV AGGARWAL New on this filingPreviously held: Health Insurance Specialist, CMS; Senior Health Advisor (Detailee), Senate Finance Committee/Sen. Ron Wyden; Social Science Research Analyst, CMS; Intern, Sen. Feinstein; Secretarys Fellow, US Dept. of Interior
Government bodies contacted
2
Lobbying activity
1
Provide advice and strategic counsel with regard to matters that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Care Reform, Medicaid, FDA regulatory issues, and corporate tax reform.